TCI Co., Ltd. (GTSM:8436) made an offer to acquire 30% stake in Maxigen Biotech Inc. (TSEC:1783) for approximately TWD 600 million on March 8, 2021. TCI will acquire 20.8 million shares at TWD 29 per share. A minimum of 5% stake will be acquired.

Scheduled period of the public tender offer is March 10, 2021 to April 16, 2021. As of March 11, 2021, the number of shares tendered for sales has reached 12.256361 million The condition of minimum number of shares, 3.473.250 million shares minimum tender has been achieved. Taishin International Bank is the appointed institution to pay the consideration.